In contrast, mutations in Cav3.3 have not been associated with epilepsy or pain to date, although Cav3.3 protein expression is upregulated in animal models of trigeminal neuropathic pain (Montera et al., 2021). The gene discussed is CACNA1I; the disease is epilepsy.